Join to View Full Profile
126 Prospect StPawtucket, RI 02860
Phone+1 401-726-2228
Are you Dr. Lee?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Seok Lee, MD is a family physician in Pawtucket, Rhode Island.
Education & Training
New York Medical College (Brooklyn-Queens)Residency, Family Medicine, 1988 - 1991
Mass General Brigham/Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1982 - 1984
Rhode Island Hospital/Brown University HealthResidency, Pathology-Anatomic and Clinical, 1977 - 1982
Boston Children’s HospitalResidency, Pediatric Pathology, 1963 - 1965- Childrens HospitalInternship, Transitional Year, 1962 - 1963
Korea University College of MedicineClass of 1961
Publications & Presentations
PubMed
- Comparative analysis of reduced toxicity conditioning regimens between fludarabine plus melphalan and fludarabine plus busulfex in adult patients with acute lymphoblas...Jaehyun Ahn, Jae-Ho Yoon, Daehun Kwag, Gi June Min, Sung-Soo Park
Bone Marrow Transplantation. 2024-10-01 - 5 citationsResponse to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transpl...Seung-Hwan Lee, Jae-Ho Yoon, Gi June Min, Sung-Soo Park, Silvia Park
International Journal of Hematology. 2021-10-06 - 16 citationsNon-inferior long-term outcomes of adults with Philadelphia chromosome-like acute lymphoblastic leukemiaHanwool Cho, Yonggoo Kim, Jae-Ho Yoon, Jaewoong Lee, Gun Dong Lee
Bone Marrow Transplantation. 2021-04-06
Press Mentions
Johns Hopkins Bloomberg School of Public Health Appoints Marsha Wills-Karp as New Bloomberg Centennial ProfessorAugust 5th, 2021
Incidence and Risk Factors of Hepatic Veno-Occlusive disease/sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Cell Transplantation in Adults with Prophylactic Ursodiol and Intravenous Heparin or Prostaglandin E1February 1st, 2021
Impact of Donor Type on Long-Term Graft-Versus-Host disease-free/relapse-free Survival for Adult Acute Lymphoblastic Leukemia in First RemissionOctober 30th, 2020
